Close Menu

GQ Life Sciences

By Uduak Grace Thomas
As genome sequencing continues to makes inroads into clinics, established vendors and small startups are honing their informatics portfolios to tap into the growing market for software in this setting.

GenomeQuest is sponsoring an award program that will provide bioinformatics support to clinical labs that want to transition to next-generation sequencing.

GenomeQuest has kicked off an award proram that will provide bioinformatics support to five labs that want to consolidate multiple Sanger-based diagnostic tests into one next-gen sequencing-based test.

Bernd Brust has resigned as the president of molecular medicine at Life Technologies "in order to pursue other opportunities," the company said in a filing with the US Securities and Exchange Commission this week.

David Macdonald has been named CEO at Agendia. He replaces Bernhard Sixt, who led the Dutch diagnostics firm since its founding in 2003. Sixt will remain with Agendia in an "advisory capacity," Agendia said.

GenomeQuest has tapped Heidi Rehm, Madhuri Hegde, and Shashikant Kulkarni to serve on its clinical advisory board.

The deal combines Pathogenica's technology for detecting and sub-selecting pathogen genomes in human tissue with GenomeQuest's large-scale whole genome, exome, and microbiome analysis.

The Iowa researchers are using GQ-Dx to compare a patient's DNA with the human reference genome, known hearing loss mutations, and common genome variations.

Pages

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.